Cardiogenic Shock 🔥

Cardiogenic shock is defined as a clinical state where oxygen delivery to the tissues is insufficient relative to the body's metabolic needs secondary to poor cardiac function or inadequate pump action of the heart.
The condition primarily results from an impairment in myocardial contractility or mechanical abnormalities of the heart.
In response to declining perfusion, compensatory homeostatic mechanisms are activated, which unfortunately become counterproductive in the setting of a failing heart.
Elevated systemic vascular resistance (SVR) increases the afterload on an already compromised myocardium.
Sympathetic discharge leads to elevated heart rate and contractility, which increases myocardial oxygen demand and may worsen ischemia.
Extreme tachycardia severely impairs diastolic filling, leading to a further decrease in myocardial perfusion.
Elevated systemic and pulmonary pressures result in tissue edema, pulmonary congestion, and hypoxemia, while ischemia further compromises ventricular diastolic compliance.

The underlying causes of cardiogenic shock in children span a variety of acquired, congenital, and metabolic conditions.

Category	Specific Causes
Inflammatory/Infectious	Acute myocarditis (often viral)
Myocardial	Dilated cardiomyopathy, restrictive cardiomyopathy, hypertrophic cardiomyopathy
Dysrhythmias	Supraventricular tachycardia, ventricular tachycardia, complete heart block, sinus node dysfunction
Metabolic	Hypoxia, severe hypoglycemia, profound acidosis, hypothermia, uremia, hypocalcemia
Toxicologic	Drug intoxication (e.g., anthracyclines, beta-blockers, calcium channel blockers, tricyclic antidepressants)
Structural/Surgical	Congenital heart disease, post-cardiac surgery

Children typically present with signs of poor peripheral perfusion accompanied by systemic and pulmonary congestion.
Fast breathing, feeding difficulties, failure to thrive, excessive sweating, and irritability are common in infants and young children.
Older children may complain of dyspnea, easy fatigability, orthopnea, abdominal pain, nausea, vomiting, palpitations, and syncope.
Examination reveals tachypnea, tachycardia, weak or thready pulse volume, and prolonged capillary refill time.
Blood pressure may be hypotensive or normotensive, depending on the success of the body's compensatory mechanisms.
Signs of systemic and pulmonary venous congestion include pallor, cyanosis, elevated jugular venous pressure, gallop rhythm, systolic/diastolic murmurs, intercostal retractions, tender hepatomegaly, and dependent edema (such as facial puffiness or ascites).

Echocardiography: The gold standard for assessing structural causes of heart failure, identifying cardiac dysfunction, estimating ejection fraction, and predicting fluid responsiveness.
Chest X-ray: Required to evaluate cardiomegaly, specific cardiac chamber enlargement, pulmonary edema, and plethora of lung fields.
Electrocardiography (ECG): Helps identify life-threatening arrhythmias, chamber hypertrophy, ST-T wave changes, and ischemic changes.
Biomarkers: Troponin I and T, and B-type natriuretic peptide (BNP) help differentiate respiratory distress of cardiac origin from pulmonary causes and predict outcomes.
Laboratory Investigations: Arterial blood gas (ABG) for pH and base deficit, lactate (to quantify tissue hypoperfusion), complete blood count, and comprehensive metabolic panels (electrolytes, renal, and liver function tests) to assess end-organ damage.

The two most essential targets in the management of cardiogenic shock are optimizing the delivery of oxygen to the tissues and aggressively reducing the utilization of oxygen.

Preload Assessment and Optimization:
- Right ventricular preload is assessed clinically via jugular venous distension, hepatomegaly, and central venous pressure, while left ventricular preload is estimated by tachypnea, crepitations, and pulmonary edema on X-ray.
- The goal is to identify a ventricular preload that augments stroke volume without causing systemic or pulmonary congestion.
- Rapid volume resuscitation can dangerously exacerbate pulmonary edema and impair myocardial function; therefore, volume expansion must be strictly gradual, utilizing 5 to 10 mL/kg boluses of normal saline over 10 to 30 minutes.
Afterload Assessment and Reduction:
- Higher diastolic blood pressure and narrow pulse volumes indicate elevated afterload.
- Once an adequate blood pressure is achieved, systemic vascular resistance should be actively decreased by administering vasodilators.
- Milrinone, a phosphodiesterase inhibitor, is frequently used as an inodilator to simultaneously lower systemic vascular resistance and improve contractility.
Optimization of Contractility:
- Inotropic agents are indicated to improve myocardial contractility but must be used at the lowest possible dose and for the shortest duration, as they inevitably increase myocardial oxygen consumption and the risk of arrhythmias.
- Dobutamine and epinephrine are commonly utilized to augment contractility depending on blood pressure parameters.

Mechanical Ventilation (PPV):
- Positive pressure ventilation (PPV) is critical; it unburdens the diaphragm and intercostal muscles, profoundly decreasing systemic oxygen utilization.
- PPV increases intrathoracic pressure, which decreases the transmural pressure of the systemic ventricle, thereby effectively reducing the afterload on the left ventricle.
Intubation Precautions:
- Endotracheal intubation in a child with cardiogenic shock carries substantial hemodynamic risks.
- Sedation and analgesia blunt endogenous catecholamines and increase systemic venous capacitance, leading to venous pooling and severely decreased right ventricular preload.
- To prevent peri-intubation cardiac arrest, pre-medication with small boluses of epinephrine may be required to maintain coronary perfusion pressure.
- Ketamine (1-2 mg/kg) is often the preferred sedative induction agent due to its cardiostable profile.
Fever Control:
- Control of fever is an under-appreciated yet vital treatment strategy; total body oxygen consumption increases by nearly 10% for every 1°C increase in body temperature.
- Aggressive use of antipyretics and cold water sponging is mandated.

Immediate recognition of poor perfusion with systemic or pulmonary congestion mandates PICU admission and continuous monitoring.
Step 1: Initiate inotropic/inodilator support, primarily Milrinone, provided the child is normotensive.
Step 2: Start careful administration of diuretics (e.g., furosemide) to reduce fluid overload and pulmonary congestion.
Step 3: Consider positive pressure ventilation, either non-invasive (CPAP/BiPAP) or invasive mechanical ventilation, to decrease venous return and left ventricular afterload.
Step 4: Reassess tissue perfusion (capillary refill time, pulse volume, lactate clearance) and urine output continuously.
Step 5 (Improvement): If perfusion improves significantly, wean inotropes gradually over 48 to 72 hours and obtain a pediatric cardiology consultation for long-term care.
Step 6 (No Improvement): If there is no clinical improvement, add an Epinephrine infusion and titrate carefully. Optimize ventilator support and adjust Positive End-Expiratory Pressure (PEEP).
Step 7 (Refractory Shock): If the child continues to deteriorate despite maximal medical and ventilatory therapy, consider initiating Extracorporeal Membrane Oxygenation (ECMO) or other extracorporeal life support measures.